Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net income	$ 26,470	$ 91,783
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	76,368	80,061
Amortization of contract acquisition costs	1,596	1,345
Amortization of debt issuance costs	801	735
Imputed interest expense and fair value adjustments to contingent consideration, net	6,864	2,070
Provision for credit losses	1,677	1,561
(Gain) loss on disposal of assets	1,176	1,587
Loss on dissolution of subsidiary	301	0
Impairment losses	11,083	13,299
Deferred income taxes	(12,288)	(8,216)
Excess tax benefit from equity-based awards	1,807	(1,256)
Equity-based compensation expense	16,410	13,240
(Gain) loss on foreign currency derivatives	552	269
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	34,995	(37,987)
Prepaids and other assets	(1,620)	38,594
Accounts payable and accrued expenses	(8,453)	1,483
Deferred revenue and other liabilities	(44,508)	(79,755)
Net cash provided by operating activities	113,231	118,813
Cash flows from investing activities
Proceeds from sale of long-live assets	246	189
Purchases of property, plant and equipment	(54,722)	(64,564)
Acquisitions, net of cash acquired for current period and prior period, respectively	0	(142,420)
Net cash used in investing activities	(54,476)	(206,795)
Cash flows from financing activities
Net proceeds (borrowings) from line of credit	4,000	164,000
Payments on other debt	(1,929)	(2,568)
Payments of contingent consideration and hold back payments to acquisitions	(37,676)	(9,600)
Dividends paid to shareholders	(24,572)	(23,518)
Payments to noncontrolling interest	(8,407)	(9,562)
Tax payments related to issuance of restricted stock units	(2,938)	(6,980)
Net cash (used in) provided by financing activities	(71,522)	111,772
Effect of exchange rate changes on cash, cash equivalents and restricted cash	3,889	(22,226)
Increase (decrease) in cash, cash equivalents and restricted cash	(8,878)	1,564
Cash, cash equivalents and restricted cash, beginning of period	167,064	180,682
Cash, cash equivalents and restricted cash, end of period	158,186	182,246
Supplemental disclosures
Cash paid for interest	55,810	19,699
Cash paid for income taxes	35,542	32,705
Non-cash investing and financing activities
Acquisition of long lived assets through finance leases	1,560	461
Acquisition of equipment through increase in accounts payable, net	3,534	6,625
Dividends declared but not paid	$ 24,660	$ 24,554